AACC展会报告

AACC 2017:

833家参展企业
21300名国际医学界的专业观众
来自110个国家
246000平方英尺展出面积


日期:2017-08-03

与会人数创历史新高,21,300名与会者来到第69届AACC年度科学会议,开展CRISPR、移动诊断和公共卫生问题的开拓研究

题目:癌症和肿瘤,遗传学和基因组学疾病,传染病,技术,新兴技术,测序,药物滥用,护理点检测,内分泌学

圣地亚哥 - 今年出席在圣地亚哥举办的第69届AACC年度科学会议和临床实验室博览会的与会者达到了历史新高。该会议于7月30日至8月3日举行,在诊断的研究和技术方面取得了突破性进展,将广泛解决患者面临的健康难题。

截至8月2日星期三,超过21,300名实验医学专业人员和医疗行业领军者已注册参加会议,比2016年度会议出席人数增加了7.9%,也是迄今为止与会人数最多的一次。今天是会议的最后一天,预计还会有更多的与会者。

会议的亮点有五个全体会议,由生命科学界的专家主讲,话题涵盖基因组工程与CRISPR的未来及有效打击药物滥用的方法。AACC 2017年华莱士·库尔特讲师奖和CRISPR共同发明人Jennifer Doudna博士在开幕致辞中讲到了她的当前研究,旨在将这一革命性的基因编写工具改造成可以纠正致病基因的方法。

星期一的全体会议发言人Teresa K. Woodruff博士,钻研新兴的临床试验和潜在干预措施,旨在帮助年轻女性癌症患者控制其生育能力以及在化疗或放射后恢复卵巢功能。星期二的全体会议与Jay Shendure,MD博士一起深入研究了大规模并行DNA测序技术,即将出现的新技术,以及这些技术在临床医学中的应用。星期三,医学博士Victoria Fraser主讲,研讨了临床实验室可以用来抑制抗生素耐药性传播的策略和诊断工具。而在今天的闭幕演讲中,A. Thomas McLellan博士强调,为了在对药物滥用的斗争中取得实质进展,戒药瘾是日常保健重点。

此外,在一个特别的会议中,Qualcomm Tricorder XPRIZE大赛的冠军和两名决赛选手介绍了他们用长达五年时间开发的移动诊断设备,该设备是受到科幻片《星际迷航》的启发而发明的,它能诊断十三种健康状况和实时捕捉影响健康的重要迹象。

第69届AACC临床实验室展览会共有833家参展商, 占地面积24.6万平方英尺,也是AACC史上场地最大的展会。 这个富有活力的展会有所有检验医学学科的开创性实验展示,包括移动健康,分子诊断,质谱,点对点和自动化实验。

“我们感到非常高兴的是,今年的AACC年度科学会议吸引了空前多的参会者。” AACC首席执行官Janet B. Kreizman表示,“证明了这个会议是提出创新性研究和技术的首要论坛,这是促进实验室医学和病人护理的关键。我期待在明年的会议上会有新的突破呈现,AACC年度科学会议不断成长,将继续推动实验室医学和医疗保健的未来发展。”

第70届AACC年度科学会议和临床实验室博览会将于2018年7月29日至8月2日在芝加哥举行。

关于第69届AACC年度科学会议和临床实验室博览会
从7月30日至8月3日,AACC年度科学会议为您提供5天的时间通过多种方式了解前沿的科学技术。全体会议涵盖的主题包括CRISPR生物学的最新研究,保护癌症患者的生育能力,DNA测序的新应用,抗生素耐药性的挑战,以及对物质滥用障碍的有效护理等内容。

在AACC临床实验室博览会上,有833多家参展商将在圣地亚哥会议中心的展厅,展示最新的诊断技术,包括但不限于移动健康,分子诊断,质谱,点对点 和自动化技术。

关于AACC
AACC致力于通过实验室医学让生命更健康,这里汇集了来自世界各地研究临床化学、分子诊断、质谱、翻译医学、实验室管理和其它实验室科学进展的领域的五万多位临床实验室专业人士、医师、研究科学家和商业领袖。自1948年以来,AACC一直致力于推动行业的共同利益,提供新项目以帮助大家进行科学合作、知识获取、专业强化和发展创新。欲了解更多信息,请访问www.aacc.org。


A Record-breaking 21,300 Attendees Came to the 69th AACC Annual Scientific Meeting for Its Pioneering Research on CRISPR, Mobile Diagnostics, and Public Health Issues

Date: AUG.3.2017

Topics: Cancer and Tumors, Genetics and Genomics Disorders, Infectious Diseases, Technology, Emerging Technology, Sequencing, Drug Abuse, Point of Care Testing, Endocrinology
SAN DIEGO – Attendance at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo reached a record high at this year’s conference in San Diego. Held from July 30-August 3, the meeting featured groundbreaking advances in diagnostic research and technology that will solve a broad range of challenging patient health problems.

As of Wednesday, August 2, more than 21,300 laboratory medicine professionals and healthcare leaders had registered for the meeting, which is a 7.9% increase over meeting attendance in 2016 and the highest number of attendees that have come to the meeting in its history. More attendees are expected today, the last day of the meeting.

Highlights of the conference program included five plenary talks presented by life sciences visionaries on subjects ranging from the future of genome engineering with CRISPR to strategies for effectively combating substance abuse. Jennifer Doudna, PhD, winner of AACC’s 2017 Wallace H. Coulter Lectureship Award and co-inventor of CRISPR, gave the opening keynote on her current research to refine this revolutionary gene editing tool into a method that could correct disease-causing genes.

Monday’s plenary speaker, Teresa K. Woodruff, PhD, DSc, delved into emerging clinical tests that can help young female cancer patients to manage their fertility as well as potential interventions that could restore ovarian function after chemotherapy or radiation. Tuesday’s plenary with Jay Shendure, MD, PhD, gave an in depth look at massively parallel DNA sequencing techniques, new technologies on the horizon, and the applications of these techniques in clinical medicine. On Wednesday, Victoria Fraser, MD, discussed the strategies and diagnostic tools that clinical labs can use to curb the spread of antibiotic resistance. And in today’s closing keynote, A. Thomas McLellan, PhD, emphasized that, in order for true progress to be made in the fight against substance abuse, treatment for addiction must be considered essential to routine healthcare.

Additionally, in a special session, the winner and two finalists from the Qualcomm Tricorder XPRIZE competition described their 5-year odyssey to develop mobile diagnostic devices inspired by the fictional Star Trek tricorder that diagnose 13 health conditions and capture real-time vital health signs.

The 69th AACC Clinical Lab Expo featured 789 exhibitors and covered 246,000 net square feet, also making this the largest show floor in AACC’s history. This dynamic exhibit featured groundbreaking tests from all laboratory medicine disciplines, including mobile health, molecular diagnostics, mass spectrometry, point-of-care, and automation.

“We are thrilled that this year’s AACC Annual Scientific Meeting drew a record-breaking number of attendees,” said AACC CEO Janet B. Kreizman. “This affirms that this meeting is the premier forum for presenting innovative research and technology that is key to advancing laboratory medicine and patient care. I look forward to seeing what new breakthroughs will be unveiled at next year’s conference as the AACC Annual Scientific Meeting continues to grow and drive laboratory medicine and healthcare into the future.”

The 70th AACC Annual Scientific Meeting & Clinical Lab Expo will be held in Chicago from July 29–August 2, 2018.

ABOUT THE 69TH AACC ANNUAL SCIENTIFIC MEETING & CLINICAL LAB EXPO
The AACC Annual Scientific Meeting offers 5 days packed with opportunities to learn about exciting science from July 30–August 3. Plenary sessions feature the latest research on CRISPR biology, preserving fertility for cancer patients, new applications for DNA sequencing, the challenges of antibiotic resistance, and effective care for substance abuse disorders.

At the AACC Clinical Lab Expo, more than 750 exhibitors will fill the show floor of the San Diego Convention Center, with displays of the latest diagnostic technology, including but not limited to mobile health, molecular diagnostics, mass spectrometry, point-of-care, and automation.

ABOUT AACC
Dedicated to achieving better health through laboratory medicine, AACC brings together more than 50,000 clinical laboratory professionals, physicians, research scientists, and business leaders from around the world focused on clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of progressing laboratory science. Since 1948, AACC has worked to advance the common interests of the field, providing programs that advance scientific collaboration, knowledge, expertise, and innovation. For more information, visit www.aacc.org.



========================================================

AACC 2016-2018年战略计划
AACC在实施2013年设定的战略计划方面取得了巨大的进步。为了加速前进步伐,2013-2015年的计划包含五个目标领域和十九项策略以指导协会活动、达成协会使命。2016-2018年的计划在上一个计划的基础上设立,过往的成功让我们更坚定不移的去执行新的计划。在当前发展趋势下,新的计划依然以协会的使命和愿景为前提。根据现今的实验室医学环境,为全面满足各专家的需求,我们扩展了策略规划范围,但协会的使命和愿景始终是我们优先考虑的。

AACC的愿景:
通过实验室医学改善人们健康水平和完善医疗保健系统。

AACC的使命:
AACC致力于推动全球临床实验室科学及医学行业在实践和专业方面的进步。

2016-2018年计划的方向和重点
生物医疗上的发现、技术上的创新和医疗保健环境的改变让实验室医学迅速发展。以疗效为付款依据的模式逐渐形成,我们必须要调整对实验室医学事务的思考方式。随着医疗知识的不断增多,懂基础疾病生物进程的临床医生不能保证也很了解基础实验室化验知识。因此,实验室主任接受专门的化验学博士级培训,并把学到的知识传授给医疗保健团队成员。新的诊断发现和诊断技术将不断增多,实验室主任的角色至关重要,他们必须保证化验模式得以正确应用,化验结果也有迹可循。

作为实验室医学专家的首要协会,AACC要着重加强在科教方面的研究。这些研究将满足博士生会员与时俱进的需要。而且,AACC要成为临床实验室专家们的社交场合,也是他们发展有价值合作的场合。AACC要做好自身定位,加强会员们的整体意识和相互理解关系,给医疗保健队伍带来特别的专业知识,也要在行业重要政策事务问题上发声。最后,AACC要确保足够的资源来让组织蓬勃发展,使其能持续为会员和利益相关者提供宝贵的项目和服务。

在2013年,AACC的领导者呼吁会员们成为改革伙伴,共同致力于达成协会的使命和愿景。众多会员响应,并积极参与了AACC的倡议和活动。2016年初,有更多人志愿加入新的委员会,为2016年的管理改革服务。我们即将进入到执行战略计划的下一个阶段,继续执行2013年制定的重点计划,并不断根据当前形式作出调整,在这一过程中,我们还要依靠AACC志愿领导们的积极参与。

目标领域1:会员社团
提供有意义的、丰富的会员活动,让实验室医学专家们可以在此社交、合作,与更大的实验室医学团体保持联系。

目标领域2:科学与创新
推动实验室医学理论的发展和其在医疗保健中的应用,提交患者的疗效。

目标领域3:内容与教育
提供即时和前沿的信息,加强关于实验室医学理论的了解,提高患者护理水平并改善其健康状况。

目标领域4:宣传与影响力
提高对实验室医学价值和临床实验室专家知识的认识,鼓励并推进对行业有影响、对AACC会员职业生涯有促进作用的政策实施。

目标领域5:资源和能力
加强和发展协会的财力,确保其保持活力和增长,也确保其基础设施和管理与目标一致。


AACC Strategic Plan 2016-2018

AACC has made tremendous progress in implementing its previous Strategic Plan, set in place in 2013. The result of an intense process, the 2013-2015 plan included five goal areas and 19 strategies to guide the association’s activities as it worked to advance its mission. The 2016-2018 plan builds upon the previous plan and the successes realized as a result of unwavering commitment to executing that plan. In the context of current trends, the new plan stays true to the association’s vision and mission, maintaining a focus on constant priorities even while extending the plan's strategies to ensure AACC meets the needs of the full breadth of professionals in today’s laboratory medicine environment.

AACC’s Vision:
Better health and healthcare through laboratory medicine.

AACC’s Mission:
AACC provides global leadership in advancing the practice and profession of clinical laboratory science and medicine.

Direction and Priorities for 2016-2018

Laboratory medicine is rapidly evolving as a result of biomedical discoveries, innovations in technology, and the changing healthcare environment. The shift toward outcomes-based payment models has already begun and we must adjust the way we think about the business of laboratory medicine. As medical knowledge continues to expand, clinicians with vast knowledge of biological processes underlying disease cannot also have deep knowledge of the science underlying laboratory tests. With their specialized doctoral-level training in the science of tests, laboratory directors provide this unique knowledge to the healthcare team. With an ever-growing array of new diagnostic discoveries and technologies, the laboratory director is crucial to ensuring the right testing paradigm is applied and the results interpreted in the context of all available knowledge.

As the premier association for laboratory medicine professionals, AACC must emphasize cutting-edge research in its science and education programs. This approach will address the needs of doctoral-level members in keeping abreast of the latest developments. Further, AACC must be known among all clinical laboratory professionals as the place where they can network and nurture valuable collaborations. AACC must be positioned well to enhance general awareness and understanding of the unique expertise its members bring to the healthcare team and to serve as the voice of the field in important policy matters. Finally, AACC must ensure sufficient resources to thrive as an organization so that it can continue to offer its valuable programs and services to its members and stakeholders.

In 2013, AACC’s leaders called on members to be change partners engaged in advancing the association’s mission and vision. Many answered that call and remain active in AACC initiatives and programs. Many more volunteered in early 2016 to serve on one of the new committees instituted as part of the 2016 governance changes. As we move into the next phase of implementing the strategic priorities first identified in 2013, and refined in the current strategic plan, we will continue to rely on the active participation of AACC’s dedicated volunteer leaders.

Goal Area 1: Member Community

Provide a meaningful and rich member experience in which laboratory medicine professionals can network, collaborate, and connect to the larger laboratory medicine community

Goal Area 2: Science & Innovation
Advance new knowledge in laboratory medicine and its application to healthcare to improve patient outcomes

Goal Area 3: Content & Education
Provide contemporary and cutting-edge information to enhance knowledge in the field of laboratory medicine for the advancement of patient care and improved health outcomes

Goal Area 4: Advocacy & Influence
Enhance awareness of the value of laboratory medicine and of the unique knowledge of clinical laboratory experts, and advocate for policies that affect the field and improve the professional lives of AACC members

Goal Area 5: Resources & Capacity
Strengthen and expand the association’s financial resources to ensure continued vitality and growth and ensure its infrastructure and governance align with its goals